SQZ-TAC
associated with 7 other trademarks
Cells for medical use, namely, for use in creating cell-based therapies encapsulating peptide and protein antigens for the treatment of auto-immune or...

Words that describe this trademark:

peptide protein  protein antigens  immune activation  encapsulating  autoimmune  antigens  cellbased  treatment  therapies  aberrant 

Serial Number:

88385646

Mark:

SQZ-TAC

Status:

Abandoned-No Statement of Use filed

Status Date:

04-24-2023

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Cells for medical use, namely, for use in creating cell-based therapies encapsulating peptide and protein antigens for the treatment of auto-immune or aberrant immune activation disorders for medical purposes Cell-based therapy services for the treatment of auto-immune or aberrant immune activation disorders featuring cells encapsulating peptide and protein antigens for medical purposes

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Trademark

Published for Opposition Date:

01-28-2020

Mark Drawing Status:

Standart Character Mark

Abandon Date:

04-24-2023

Business Name:

LATHAM & WATKINS LLP

Correspondent Name:

Recent Trademark filings by this company